{"task_id": "eca43576c9ee7b14", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 290/464)", "text": "tumors [lymphoma,\n280\nSystemic Lupus Erythematosus\n\n--- Page 302 ---\nSPECIFIC ENTITIES (CONT\u2019D)\ncarcinoid syndrome, pheochromocytoma], occlu\nsive arterial disease, hyperviscosity, hypothyroid\nism, Parvovirus B19, PBC)\n\u0002\nCLINICAL FEATURES\nusually symmetric episodes of\nsharply demarcated color changes of the skin and\nsevere pain of the digits lasting 10 15 min. Sec\nondary causes more likely if age >40, male, ulcera\ntions, asymmetric, involvement proximal to digits\nand abnormal capillary nailfold\n\u0002\nTREATMENTS\navoidance (cold, stress, smoking,\nsympathomimetic drugs). Keep core temperature\nstable. Terminate attacks early (place hands in\nwarm water). Calcium channel blockers (nifedipine\n10 60 mg PO TID, amlodipine 5 20 mg PO daily).\nTopical nitrates. ASA. Anticoagulate (if antipho\nspholipid antibodies or surgical interventions\nrequired)\nRelated Topic\nCutaneous Lupus Erythematosus (p. 371)\nSCLERODERMA\n\u0002\nPATHOPHYSIOLOGY\nextensive\nfibrosis and some\ndegree of inflammation of skin, blood vessels, and\ninternal organs (GI, lungs, renal, cardiac). There are\nfour subtypes, including diffuse systemic sclerosis\n(progressive systemic sclerosis), limited systemic\nsclerosis wCRESTw syndrome (Calcinosis, Ray\nnaud\u2019s phenomenon, Esophageal dysmotility, Scler\nodactyly, Telangiectasias), localized scleroderma\n(morphea, linear), and scleroderma sine scleroderma\n\u0002\nCLINICAL FEATURES\nRaynaud\u2019s phenomenon may\nprecede skin changes for years. Usually involves\nthe skin (starts from extremities extending proxi\nmally, progressing from edematous to fibrotic to\natrophic stage. Common signs include dilated capil\nlary loops, sclerodactyly, flexion contractures, hypo\npigmentation, hyperpigmentation, \u2018\u2018coup de sabre\ndeformity\u2019, purse lip, telangiectasia), and GI hypo\nmotility (dry mouth, dysphagia, dyspepsia, N&V,\nabdominal pain, constipation, diarrhea, weight\nloss). The lungs (pleural effusion, pulmonary fibrosis,\npulmonary hypertension), kidneys (renal crisis), and\nheart (pericarditis) may also be involved\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nDIAGNOSIS\nmajor criterion is sclerodermatous skin\nchanges proximal to the MCP joints. Minor criteria\ninclude sclerodactyly, digital pitting scars, and\nbilateral pulmonary fibrosis. Tests include antibo\ndies to topoisomerase I (anti SCI 70) seen more in\ndiffuse systemic sclerosis and antibody to centro\nmere seen more in CREST\n\u0002\nTREATMENTS\nRaynaud\u2019s (calcium channel block\ners). GERD (proton pump inhibitor). Renal crisis\n(ACE inhibitors). Interstitial pneumonitis (steroids,\nazathioprine,\ncyclophosphamide).\nPulmonary\nhypertension (endothelin antagonists [Bosentan])\nINFLAMMATORY MYOPATHIES\n\u0002\nPATHOPHYSIOLOGY\nclassified as polymyositis, der\nmatomyositis, and inclusion body myositis\n\u0002\nASSOCIATIONS\ndermatomyositis is associated with\nmalignancy (GI, lung, ovarian, breast, lymphoma)\nin 6 45% of patients\n\u0002\nCLINICAL FEATURES\nproximal, symmetric, progres\nsive muscle weakness developing over weeks to\nmonths, may be associated with morning stiffness.\nMuscle pain is not common. Extramuscular mani\nfestations include arthralgias, cardiac (conduc\ntion abnormalities, cardiomyopathy), respiratory\n(muscle weakness, aspiration, interstitial lung dis\nease), skin (Gottron\u2019s papules [dorsal aspect of\nMCP and IP joints/elbows/knees], heliotrope rash\n(over upper eyelids with periorbital edema), V\nrash/shawl sign [erythematous rash over upper\nchest/back/shoulders], periungual telangiectasia,\nmechanic\u2019s hand [with darkened horizontal lines\nacross lateral and palmar aspects of fingers/\nhands]), and constitutional symptoms. Reflexes\nare usually normal\n\u0002\nDIAGNOSIS\nsymmetric proximal weakness, eleva\ntion of muscle enzymes, EMG findings consistent\nwith inflammatory myositis, muscle biopsy consis\ntent with inflammatory myositis. Need all four\ncriteria for definite polymyositis, and three criteria\nplus skin findings for definite dermatomyositis.\nImportant to exclude other causes of myopathies.\nAnti Jo1, anti Mi2, anti SRP\n\u0002\nTREATMENTS\nprednisone, methotrexate, azathiop\nrine, leflunomide, IVIG\nDISTINGUISHING FEATURES BETWEEN STEROID MYOPATHY AND INFLAMMATORY MYOPATHIES\nSteroidmyopathy\nInflammatory myopathies\nHistory\nSteroid use\nOther steroid related symptoms\nOther inflammatory myopathy symptoms\nPhysical\nNeck flexor normal\nNeck flexor weaker\nTests\nCK less often \"\nCK often \", anti Jo1/anti Mi2 Ab\nEMG\nNormal\nAbnormal activity\nStop steroid\nImproves\nWorsens\nSystemic Lupus Erythematosus\n281", "text_length": 4420, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 290/464)", "type": "chunk", "chunk_index": 289, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.643699", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.644556", "status": "complete", "chunks_added": 3}